Gilead Sciences (GILD) Tops Q2 EPS by 41c, Updates Guidance

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/8/2026

Get Alerts GILD Hot Sheet

Price: $136.49 +0.10%

Revenue Growth %: +4.4%

Financial Fact:
Income from operations: 4.4B

Today's EPS Names:
CRMT, PKE, HELE, More

Join SI Premium – FREE

Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $2.56, $0.41 better than the analyst estimate of $2.15. Revenue for the quarter came in at $7.14 billion versus the consensus estimate of $6.35 billion.

GUIDANCE:

Gilead Sciences sees FY2017 revenue of $24-25.5 billion, versus the consensus of $24.8 billion.

Revised Full Year 2017 Guidance

Gilead revised its full year 2017 guidance, initially provided on February 7, 2017:

(In millions, except percentages and per share amounts)	Initially Provided February 7, 2017 Reiterated May 2, 2017	Updated July 26, 2017
Net Product Sales	$22,500 - $24,500	$24,000 - $25,500
Non-HCV Product Sales	$15,000 - $15,500	$15,500 - $16,000
HCV Product Sales	$7,500 - $9,000	$8,500 - $9,500
Non-GAAP*
Product Gross Margin	86% - 88%	86% - 88%
R&D Expenses	$3,100 - $3,400	$3,200 - $3,400
SG&A Expenses	$3,100 - $3,400	$3,200 - $3,400
Effective Tax Rate	25.0% - 28.0%	25.0% - 28.0%
Diluted EPS Impact of Acquisition-related, Up-front Collaboration, Stock-based Compensation and Other Expenses	$0.84 - $0.91	$0.86 - $0.93

For earnings history and earnings-related data on Gilead Sciences (GILD) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

Create E-mail Alert Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities

Earnings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!